|Publication number||USRE35987 E|
|Application number||US 08/385,285|
|Publication date||Dec 8, 1998|
|Filing date||Feb 8, 1995|
|Priority date||Jun 5, 1990|
|Also published as||CA2043813A1, EP0524321A1, US5184617|
|Publication number||08385285, 385285, US RE35987 E, US RE35987E, US-E-RE35987, USRE35987 E, USRE35987E|
|Inventors||Frank W. Harris, Alan R. Owens|
|Original Assignee||Staodyn, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (29), Referenced by (91), Classifications (5), Legal Events (6)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This invention relates to an electronic device for producing a pulse output signal for therapeutic purposes, and, more particularly, relates to output pulse compensation for such a device.
Electronic devices capable of providing a pulse output signal for therapeutic purposes are now well known, and such devices are known, for example, to include transcutaneous electrical nerve stimulating (TENS) devices and muscle stimulating devices. It is also well known that such devices commonly include externally accessible controls for effecting parameter changes, including changes in pulse width and intensity of the delivered pulses (see, for example, U.S. Pat. No. 4,014,347).
Conventional TENS and muscle stimulator devices commonly use constant current feedback to regulate the charge per pulse. The feedback signal, representing the peak current, is compared with the reference voltage to establish the height of the rectangular pulses, and the reference voltage is usually derived from a variable control device, such as a potentiometer, which serves to control the stimulation intensity. In other words, stimulation amplitude is commonly controlled by varying the peak current of the rectangular current pulses.
It has been found that, at least with respect to TENS devices and muscle stimulator devices, that large pulse widths are useful for short term stimulation since they are more comfortable to the user than narrow pulse width for the stimulation of large muscles. Conversely, narrow pulse widths are more comfortable to the user for stimulating small muscle groups, and narrow pulse widths are particularly well suited for use for long term stimulation which often occurs, for example, in effective stimulation by a TENS unit.
It is usually necessary, or at least desirable, that the pulse width be tuned (i.e., varied) while using the unit. However, since the charge per pulse varies directly with the pulse width, unless the peak current is also adjusted whenever the pulse width is changed, the charge per pulse will also change.
Since stimulation intensities perceived by a user are approximately proportional to the delivered charge per pulse, a wide pulse will acquire a large amount of charge when the intensity control is moved only slightly in the intensity increase direction. Conversely, when the pulse width is narrow, changing the peak current a small amount, by moving the intensity control in the intensity increase direction, will produce a small amount of increase in the charge per pulse. Since pulse width affects the sensitivity of the intensity control where both are utilized in a device, using a pulse width, for example, of greater than about 200 microseconds, causes conventional amplitude controls to become overly sensitive. As a result, pulse widths greater than about 200 microseconds are difficult to control with an ordinary potentiometer-type amplitude, or intensity, control.
In addition, the pulse width of the pulses being delivered sometimes causes confusion with respect to the amount of charge being delivered, or at least perceived to be delivered. For example, if the pulse is 100 ma peak and 200 microseconds wide, the pulse contains 20 microcoulombs charge. While such a charge would normally be too strong to be tolerated with small electrodes such as are commonly used with TENS units, for example, such a charge could easily and safely be tolerated with comfort if sufficiently large electrodes are utilized (i.e., the area of application is made sufficiently greater).
It was therefore found that if the intensity was increased as the pulse width was decreased, and if the intensity was decreased as the pulse width was increased, the charge delivered by the pulses can be controlled to produce a more constant level of stimulation. A strength-duration curve to effect this end was suggested in connection with a diagnostic apparatus (see, U.S. Pat. No. 2,808,826), and has also been suggested for use in connection with TENS units (see U.S. Pat. Nos. 4,431,002 and 4,453,548). In addition, such a curve has been suggested for use in connection with mechanical coupling of pulse width and amplitude controls in a stimulator (see U.S. Pat. No. 4,340,063), such a curve has been suggested for use in connection with scanning output parameters through predetermined ranges to periodically achieve optimum stimulating currents (see U.S. Pat. No. 4,210,151), and such a curve has also been suggested for use in conjunction with strength-duration-rate modulation in a TENS device (see U.S. Pat. No. 4,759,368).
It has also been heretofore suggested that the intensity of the delivered output pulses can be controlled, and gradual increase in such intensity is utilized, for example, in the NuWave® TENS unit now being sold by the assignee of this invention.
Thus, while pulse compensation has heretofore been suggested in connection with therapeutic-type devices, improvements and/or additions to such devices could further improve such devices.
This invention provides improved output pulse compensation for therapeutic-type electronic devices. Output pulse compensation is automatically provided upon sensing of predetermined changed conditions being monitored, and such compensation is preferably accomplished using a micro-computer in devices constructed according to this invention.
When such a changed condition is sensed that is capable of causing user discomfort, or possible injury, the intensity of the pulses then being delivered is quickly reduced and then gradually increased to the full then requested intensity (unless intensity reduction is again effected due to sensing of a condition being monitored) to thus provide a soft-start.
Upon sensing a change in pulse width initiated by a change of the pulse width control, a predetermined corresponding change in the range of intensities of the pulses then delivered is also effected, based upon the nerve fiber strength-duration curve of the pulses, to thereby maintain the charge delivered per pulse substantially constant, with the percentage of intensity of each pulse being also maintained substantially constant unless a change in percentage is initiated by an intensity control that operates independently of the pulse width control.
It is therefore an object of this invention to provide improved output pulse compensation for a therapeutic-type electronic device.
It is another object of this invention to provide improved proved output pulse compensation that is automatically provided upon sensing of a predetermined changed condition being monitored.
It is still another object of this invention to provide improved output pulse compensation by quickly reducing the intensity of pulses then being delivered upon sensing of a monitored condition capable of causing discomfort or injury, and then gradually increasing the intensity to the requested intensity unless again caused to be reduced due to sensing of a monitored condition.
It is another object of this invention to provide improved output pulse compensation for a therapeutic-type electronic device utilizing a change in the range of intensities corresponding in a predetermined manner to a change in pulse width.
It is another object of this invention to provide improved pulse compensation for therapeutic-type electronic device wherein a change in the range of intensities, corresponding in a predetermined manner to a change in pulse width, is based upon a nerve fiber strength-duration curve.
It is still another object of this invention to provide improved pulse compensation for a therapeutic-type electronic device utilizing a change in the range of intensities, corresponding in a predetermined manner to a change in pulse width, to thereby maintain the charge delivered per pulse substantially constant.
It is yet another object of this invention to provide improved compensation for a therapeutic-type electronic device utilizing a micro-computer to sense monitored conditions and cause output pulse intensity changes in response thereto.
With these and other objects in view, which will become apparent to one skilled in the art as the description proceeds, this invention resides in the novel construction, combination, arrangement of parts and method substantially as hereinafter described, and more particularly defined by the appended claims, it being understood that changes in the precise embodiment of the herein disclosed invention are meant to be included as come within the scope of the claims.
The accompanying drawings illustrate a complete embodiment of the invention according to the best mode so far devised for the practical application of the principles thereof, and in which:
FIG. 1 is a block diagram of a TENS unit having output pulse compensation according to this invention supplied by a micro-computer included as a part of the TENS unit;
FIG. 2 is a schematic diagram illustrating an output stage as shown in FIG. 1;
FIGS. 3 through 5 are flow charts illustrating operation of the micro-computer shown in FIG. 1 to control the intensity of the output pubes in response to monitored conditions:
FIG. 6 is a graph of a typical nerve fiber strength-duration curve;
FIG. 7 is a plot of a strength-duration look-up table based upon the strength-duration curve of FIG. 6; and
FIGS. 8A and 8B show a flow chart illustrating operation of the micro-computer shown in FIG. 1 to effect output pulse compensation by varying the range of intensities of the output pulses due to pulse width adjustment.
In this invention, output pulse compensation is automatically provided for a therapeutic-type electronic device when a predetermined change is sensed to occur in a condition being monitored. This includes, for example, monitoring of conditions to prevent user discomfort, or possible injury, due to delivery of output pulses at undesirably high intensity levels, as well as monitoring variations imposed by the user, as, for example, varying the requested pulse width of the pulses to be delivered.
Users have been found to be occasionally startled or even shocked by improper use of nerve stimulators or by defective stimulation units. These incidents are normally characterized by a sudden, perceived increase in the stimulation intensity that surprises the user, and can happen in a number of different ways, including, for example, an abrupt increase in the intensity caused by a requested increase by the intensity control or by a sudden increase in intensity occasioned by battery replacement, loose or intermittent electrode leads, rapid switching between modes, and/or defects causing the device to be reset accidently.
In this invention, monitored conditions are sensed, or detected, preferably using a micro-computer having appropriate algorithms. The algorithms eliminate surprise, and prevent discomfort or possible injury, by resetting the stimulation intensity of the output pulses being then delivered to a low (or zero) level, and then gradually increasing the stimulation intensity up to the level requested by the setting of the intensity control.
Output pulse compensation, according to this invention, is illustrated in FIG. 1 in connection with a TENS device. It is meant to be appreciated, however, that such compensation can be effected with other therapeutic-type devices in the same manner. The TENS device illustrated in FIG. 1 is a plural channel device, but it is meant to be realized that a single channel device could also be utilized.
Referring now to FIG. 1, TENS device 7 includes micro-computer, or controller, 9 that receives an input indicative of intensity, or amplitude, from amplitude control potentiometers 11 and 13 (if plural channels are utilized) and an input indicative of pulse width from pulse width control potentiometer 15. In addition, TENS device 7 can also receive an input indicative of pulse rate from pulse rate control potentiometer 17, as is conventional.
As indicated in FIG. 1, the control inputs (from potentiometers 11, 13, 15 and 17) are coupled to microcomputer 9 (which preferably includes analog-to-digital (A/D) converter 19). Micro-computer 9 is connected with power supply 21 (5 volts), and power supply 21 is connected to battery 23 (9 volts) through on-off switch 25. Battery 23 also provides power to high voltage power inverter 27, which inverter supplies high voltage to the output stages 29 and 31 (if plural channels are utilized), as is conventional for TENS units. The output stage, or stages, are preferably conventional asymmetric biphasic, but can also be symmetrical biphasic.
As also indicated in FIG. 1, a multi-mode operation can be established for the device using latch 33 (a 4 bit latch), to hold the then selected mode, and mode switch 35.
As is conventional, micro-computer 9 generates pulses for each channel utilized (using appropriate algorithms in connection with timer 37, which timer is preferably a part of the micro-computer), and these pulses are coupled to the output stage, or stages, to enable the pulse output signals to be conventionally provided by the device.
As also shown in FIG. 1 micro-computer 9 has also included therein output pulse compensation algorithms and a look-up table with the output being coupled through digital-to-analog (D/A) converter 39 (also preferably a part of micro-computer 9 as shown in FIG. 1). Converter 39 supplies a reference voltage to one input of operational amplifier 41. The other input of operational amplifier 41 is connected with current sense resistor 43, and the output of operational amplifier 41 is coupled to the output stage, or stages. 29 and 31.
Output stages 29 and 31 may be identical and output stage 29 is shown in detail in FIG. 2. As shown, the high voltage is coupled to high voltage gate transistor 47 of output stage 29, and transistor 47 also receives the pulse logic input from micro-computer 9. The output pulses are delivered to a user through lead 49, with the return path from the user being through lead 51, capacitor 53, and diode 55 (with lead 49 being connected to the junction of capacitor 53 and diode 55 through bleed resistor 57).
As also shown in FIG. 2, analog control transistor 59 is connected with the output of operational amplifier 61. Amplifier 61 has one input connected to receive a reference voltage and the other input connected with transistor 59 and is connected with ground through sense resistor 63.
As also shown, a +5 volt power supply is connected to one side of resistor 65. The other side of resistor 65 is connected to one side of diode 67, with the other side of diode 67 being connected to the junction of diode 55 and transistor 59. Gate transistor 69 of sample and hold circuit 71 is connected with the junction of resistor 65 and diode 67 through parallel-connected capacitor 73 and resistor 75 (having resistor 77 to ground connected therewith). The pulse logic from microcomputer 9 is also coupled to transistor 69, and the output from transistor 69 is stored in capacitor 79, which capacitor is connected with A/D convertor 19 of micro-computer 9.
The implementation of the algorithms used in microcomputer 9 (as illustrated in FIGS. 3 through 5) requires the use of the sample-and-hold circuit to measure the output transistor saturation during pulses for each channel (the circuit is necessary only where the pulse rate of the TENS unit is variable since, if the rate is fixed, a simple R-C averaging circuit attached to the analog control transistor drain could produce an appropriate voltage value proportional to the drain voltage during the pulses).
The flow chart, as shown in FIG. 3, provides a test for output errors, the flow chart, as shown in FIG. 4, provides for control of the intensity of the delivered output pulses (preferably every ten milliseconds), and the flow chart, as shown in FIG. 5, provides for mode selection (an intermittent lead routine may also be utilized and differs from the reset routine illustrated in that the intensity is reset to zero and ramp-up requires 2.55 seconds, which is 255 steps of 1/100 second).
The algorithm is initiated by unit reset, change of operating mode, or intermittent lead detection.
When the unit is reset, the initialization of the processor (i.e., the micro-computer) includes slow "ramping" of the intensity setting up to the intensity set by the externally accessible intensity control over a period of 2 seconds. The actual intensity is reset to a binary multiplier factor of "55", which is about 20% of full scale. Then the intensity is ramped up to "255", which is equivalent to a multiplier of 100% of full scale. So whenever the processor resets, the intensity control (or controls if dual channels are being utilized) is checked, and if it is found that the setting of the control, or controls, is at a significant level, then the intensity is ramped slowly up to that level.
Similarly, whenever a change in the mode status is detected, the same two second algorithm is implemented.
Intermittent leads require the most complicated detection algorithm. The algorithm looks for the combination of hard saturation of the output transistors plus greater than 95% of the maximum output voltage from the high voltage inverter power supply (where used in a unit having power conservation that requires monitoring of the saturation of the output transistors, saturation alone would not be a sufficient definition for open electrode leads). An open lead pair means that the supply voltage is at maximum and the output transistor is fully saturated.
To measure the drain voltage of the output transistor, the output stage analog control transistor drain is monitored by sample-and-hold circuit 71, as shown in FIG. 2. Transistor 69 is gated on by the micro-computer during pulses to sample the drain voltage, and this voltage is stored in capacitor 79 until read by A/D converter 19. The drain voltage is converted into binary values from 0 to 255.
Sample and hold circuit 71 measures the drain voltages only in the vicinity of saturation. Drain voltages above about 5 volts are defined as not saturated and produce a maximum A/D output of 255 binary. As can be appreciated from the circuit diagram of FIG. 2, the connection to sample and hold circuit 71 becomes operative only when the drain voltage falls below 5 volts and diode 67 is forward biased.
Micro-computer 9 sees a range of saturation voltages from 0 to 255 binary. A voltage of less than "32" is defined as "hard saturation" while a value of less than "128" is defined as a high impedance electrode circuit. If the value is less than "32", the soft start reset and ramp sequence is started. However, if the value is just less than "128", then an electrode alert light (if utilized) is energized and the reset/ramp sequence is not started. An alert light indication indicates that leads and/or electrodes have too high an impedance and that the user should recheck the electrode system for such things as continuity and moist skin contact.
Output pulse compensation is also automatically provided to maintain the charge delivered per pulse substantially constant when a change occurs in the pulse width of the output pulses then being provided by the device.
To accomplish such compensation the range of the amplitude, or intensity, of the delivered output pulses is adjusted based upon a nerve fiber strength-duration curve, such as illustrated in FIG. 6.
The curve shown in FIG. 6 illustrates the relationship between the amplitude and the width and the resulting capability to stimulate the nerve fiber. From this curve, it can be seen that if the pulses have too low an amplitude (i.e., less than the "rheobase"), the nerve will never be stimulated, even if the pulse width lasts to infinity.
Pulse width compensation includes, basically, using an applicable strength-duration curve to vary the range of the peak current delivered as pulses from the device. In other words, the pulse width, as then set, determines the peak current range of the intensity control. For every pulse width, there is a corresponding current range for the intensity control.
The strength-duration curve shown in FIG. 6 is preferably implemented with a look-up table that can be read by micro-computer 9 and an illustration of such a table, based upon the curve shown in FIG. 6, is set forth in FIG. 7. As illustrated in FIG. 7, at a 50 microsecond pulse width, the intensity is automatically assigned a range of 0 to 100 milliamperes peak, while at 400 microseconds width, the assigned range is 0 to 27 milliamperes peak.
The table, as shown in FIG. 7, was determined imperically and has the following mathematical formula:
where I is current and PW is pulse width.
Whenever a new pulse width is selected by the pulse width control the micro-computer, following the thus established algorithm, determines the appropriate range of current (within which range the intensity varying, or controlling, unit (such as a potentiometer) can operate), and then generates the proper reference voltage within that current range for that pulse width. A flow chart illustrating operation of the micro-computer to effect pulse width compensation is set forth in FIG. 8.
After the determination is made at micro-computer 9, the binary number produced is coupled through D/A converter 39 to generate a reference voltage to be coupled to operational amplifier 41.
Thus, the reference voltage equals the setting percentage (of the intensity control potentiometer) x maximum peak current x K, where K is a scale factor that converts the value to the correct binary number and subsequent voltage for the particular device design.
Because the look-up table establishes a range of the intensities, there is, of course, a family of numerous strength curves .Iadd.one .Iaddend.for each possible intensity percentage setting. This enables smooth control and is normally no more distinguishable to a user than is generating the reference voltage directly using a simple potentiometer.
The look-up table, as shown in FIG. 7, is not suitable for all pulse shapes since this table was derived for use with an asymmetrical biphasic pulse generated by a capacitive output stage which has an active charge bleeder circuit, such as is commonly found in TENS-type units. In such a unit, the active bleeder circuit discharges the charge stored in the output capacitors and tissues during the brief rectangular pulses. When the pulse width is narrow and pulse rate is low, the charge can be dissipated with a simple resistor. However, when wide pulses and high pulse rates are used, the bleeder must actively discharge the capacitance by turning on a bleeder transistor between pulses. The time constant and response characteristics of the bleeder circuit partly determine the exact shape of the look-up table curve.
As an example of how the look-up table might need to be changed, when a bleeder circuit is used that discharges the capacitance more slowly, the curve that produces equal sensation is different and has the following mathematical formula:
The equation has the same form as before, but the rheobase has been shifted to account for the different pulse shape.
For other embodiments of the invention, it would be possible to perform the calculation using the exponential formula every time the pulse width changes. In practice, however, this method appears to be slow, due to the complicated operation, and difficult to implement, at least using an 8 bit micro-controller. It would also be possible to build a compensation control system using analog curve fitting techniques, but this method would appear to require tuning with multiple trim pots and therefore be far more costly.
In practice, a device with output pulse compensation, such as illustrated in FIG. 1, operates in the same manner as does a conventional TENS device, except that compensation is automatically provided by the microcomputer each time the pulse width is changed.
The use of such pulse width compensation will not normally be noticed by a user, particularly since the user is automatically protected, including protection against shock which could otherwise occur, for example, when a large pulse width is selected.
Using pulse width compensation, it is possible to adjust pulse widths while the device is in use and directly compare different pulse widths independent of the intensity (since the percentage of intensity is maintained constant unless the intensity control is also adjusted). Also, the ability to finely control intensity when utilizing wide pulse widths makes exceptionally wide pulse widths practical for use in a general purpose TENS unit or a muscle stimulator unit.
Automatic compensation of the pulse intensity range of the delivered output pulses is achieved as the pulse width is varied. Thus, the pulse height is automatically varied whenever the pulse width is changed to hold the amplitude of sensation constant.
Without an arrangement to automatically vary the intensity control potentiometer (which normally has an externally visible indicator associated therewith), the actual intensity being delivered cannot be correctly portrayed at the intensity control indicator for each of a plurality of pulse widths. The range of intensities is thus changed as the pulse width is changed. The intensity control potentiometer indicator therefore acts as a percentage indicator that consistently indicates whatever percent of the intensity range is then selected by the intensity control potentiometer. Thus, amplitude is defined as a family of strength-duration curves, with each curve representing a separate setting of the intensity control.
As can be appreciated from the foregoing, this invention provides improved output pulse compensation for an electronic device providing a pulse output for therapeutic purposes.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2263205 *||Mar 24, 1939||Nov 18, 1941||Mine Safety Appliances Co||Apparatus for the treatment of skin diseases|
|US2808826 *||Jan 19, 1956||Oct 8, 1957||Teca Corp||Electro-diagnostic apparatus and a circuit therefor|
|US3241557 *||Sep 11, 1962||Mar 22, 1966||Sutetaro Yamashiki||Low frequency therapeutic equipment|
|US3645267 *||Oct 29, 1969||Feb 29, 1972||Medtronic Inc||Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate|
|US3842844 *||Jun 30, 1972||Oct 22, 1974||Medtronic Inc||Electromedical pulse generator with continuous pulse width adjustment circuitry|
|US3901247 *||Jan 28, 1974||Aug 26, 1975||Medtronic Inc||End of life increased pulse width and rate change apparatus|
|US3908669 *||Dec 17, 1973||Sep 30, 1975||American Acupuncture Medical I||Apparatus for use by physicians in acupuncture research|
|US4014347 *||May 27, 1975||Mar 29, 1977||Staodynamics, Inc.||Transcutaneous nerve stimulator device and method|
|US4088141 *||Apr 27, 1976||May 9, 1978||Stimulation Technology, Inc.||Fault circuit for stimulator|
|US4141359 *||Aug 16, 1976||Feb 27, 1979||University Of Utah||Epidermal iontophoresis device|
|US4177819 *||Mar 30, 1978||Dec 11, 1979||Kofsky Harvey I||Muscle stimulating apparatus|
|US4210151 *||Sep 26, 1978||Jul 1, 1980||Stimtech, Inc.||Electronic pain control with scanned output parameters|
|US4340063 *||Feb 14, 1980||Jul 20, 1982||Empi, Inc.||Stimulation device|
|US4372319 *||Jun 13, 1980||Feb 8, 1983||Matsushita Electric Works, Ltd.||Low frequency therapeutic instrument|
|US4431002 *||Jun 8, 1981||Feb 14, 1984||Empi Inc.||Modulated deep afferent stimulator|
|US4453548 *||May 2, 1983||Jun 12, 1984||Empi, Inc.||Method of improving sensory tolerance with modulated nerve stimulator|
|US4520825 *||Apr 30, 1982||Jun 4, 1985||Medtronic, Inc.||Digital circuit for control of gradual turn-on of electrical tissue stimulators|
|US4539993 *||Nov 18, 1982||Sep 10, 1985||Medtronic, Inc.||Fail-safe muscle stimulator device|
|US4759368 *||Dec 2, 1986||Jul 26, 1988||Medical Designs, Inc.||Transcutaneous nerve stimulator|
|US4926865 *||Jan 17, 1989||May 22, 1990||Oman Paul S||Microcomputer-based nerve and muscle stimulator|
|US4979507 *||May 3, 1989||Dec 25, 1990||Eckhard Alt||Energy saving cardiac pacemaker|
|EP0269844A1 *||Oct 26, 1987||Jun 8, 1988||Siemens Aktiengesellschaft||Stimulator|
|EP0269848A1 *||Oct 26, 1987||Jun 8, 1988||Siemens Aktiengesellschaft||Stimulator|
|EP0339313A1 *||Apr 5, 1989||Nov 2, 1989||HENNEBERG & BRUNNER||Stimulation apparatus|
|FR2336286A1 *||Title not available|
|FR2504807A1 *||Title not available|
|FR2526180A1 *||Title not available|
|FR2528709A1 *||Title not available|
|WO1986002567A1 *||Oct 18, 1985||May 9, 1986||Zion Foundation||Method and apparatus for delivering a prescriptive electrical signal|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7158834||Dec 17, 2003||Jan 2, 2007||Atlantic Medical, Inc.||Method and apparatus for performing microcurrent stimulation (MSC) therapy|
|US7187977||Jun 10, 2003||Mar 6, 2007||Atlantic Medical, Inc.||Transcutaneous electrical nerve stimulation device and method using microcurrent|
|US7228179||Jul 25, 2003||Jun 5, 2007||Advanced Neuromodulation Systems, Inc.||Method and apparatus for providing complex tissue stimulation patterns|
|US7254444||Oct 17, 2002||Aug 7, 2007||Encore Medical Asset Corporation||Electrical nerve stimulation device|
|US7493159||Aug 6, 2003||Feb 17, 2009||Medtronic, Inc.||Trial neuro stimulator with lead diagnostics|
|US7526341 *||Mar 15, 2002||Apr 28, 2009||Medtronic, Inc.||Amplitude ramping of waveforms generated by an implantable medical device|
|US7647115||Jun 3, 2005||Jan 12, 2010||Ardian, Inc.||Renal nerve stimulation method and apparatus for treatment of patients|
|US7653438||May 13, 2005||Jan 26, 2010||Ardian, Inc.||Methods and apparatus for renal neuromodulation|
|US7717948||Aug 16, 2007||May 18, 2010||Ardian, Inc.||Methods and apparatus for thermally-induced renal neuromodulation|
|US7853333||Jun 12, 2006||Dec 14, 2010||Ardian, Inc.||Methods and apparatus for multi-vessel renal neuromodulation|
|US7937143||Oct 18, 2005||May 3, 2011||Ardian, Inc.||Methods and apparatus for inducing controlled renal neuromodulation|
|US8019426||Jul 16, 2007||Sep 13, 2011||Encore Medical Asset Corporation||Electrical nerve stimulation device|
|US8131371||Apr 13, 2006||Mar 6, 2012||Ardian, Inc.||Methods and apparatus for monopolar renal neuromodulation|
|US8131372||Mar 19, 2007||Mar 6, 2012||Ardian, Inc.||Renal nerve stimulation method for treatment of patients|
|US8131374||Aug 5, 2011||Mar 6, 2012||Encore Medical Asset Corporation||Electrical nerve stimulation device|
|US8140165||Jan 30, 2006||Mar 20, 2012||Encore Medical Asset Corporation||Independent protection system for an electrical muscle stimulation apparatus and method of using same|
|US8145316||Jul 25, 2005||Mar 27, 2012||Ardian, Inc.||Methods and apparatus for renal neuromodulation|
|US8145317||Mar 6, 2006||Mar 27, 2012||Ardian, Inc.||Methods for renal neuromodulation|
|US8150518||Jun 3, 2005||Apr 3, 2012||Ardian, Inc.||Renal nerve stimulation method and apparatus for treatment of patients|
|US8150519||Mar 6, 2006||Apr 3, 2012||Ardian, Inc.||Methods and apparatus for bilateral renal neuromodulation|
|US8150520||Mar 6, 2006||Apr 3, 2012||Ardian, Inc.||Methods for catheter-based renal denervation|
|US8175711||Mar 6, 2006||May 8, 2012||Ardian, Inc.||Methods for treating a condition or disease associated with cardio-renal function|
|US8347891||Nov 14, 2006||Jan 8, 2013||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen|
|US8428204 *||Aug 20, 2010||Apr 23, 2013||Raytheon Company||Recovering distorted digital data|
|US8433423||Dec 13, 2010||Apr 30, 2013||Ardian, Inc.||Methods for multi-vessel renal neuromodulation|
|US8444640||Sep 14, 2012||May 21, 2013||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen|
|US8454594||Aug 11, 2009||Jun 4, 2013||Medtronic Ardian Luxembourg S.A.R.L.||Apparatus for performing a non-continuous circumferential treatment of a body lumen|
|US8548600||Sep 14, 2012||Oct 1, 2013||Medtronic Ardian Luxembourg S.A.R.L.||Apparatuses for renal neuromodulation and associated systems and methods|
|US8551069||Mar 6, 2006||Oct 8, 2013||Medtronic Adrian Luxembourg S.a.r.l.||Methods and apparatus for treating contrast nephropathy|
|US8620423||Mar 14, 2011||Dec 31, 2013||Medtronic Ardian Luxembourg S.A.R.L.||Methods for thermal modulation of nerves contributing to renal function|
|US8620438||Feb 13, 2007||Dec 31, 2013||Encore Medical Asset Corporation||Method and apparatus for applying neuromuscular electrical stimulation|
|US8626300||Mar 11, 2011||Jan 7, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for thermally-induced renal neuromodulation|
|US8684998||Mar 9, 2012||Apr 1, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods for inhibiting renal nerve activity|
|US8721637||Jul 12, 2013||May 13, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons|
|US8728137||Feb 12, 2013||May 20, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods for thermally-induced renal neuromodulation|
|US8728138||Feb 12, 2013||May 20, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods for thermally-induced renal neuromodulation|
|US8740896||Jul 12, 2013||Jun 3, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons|
|US8768470||May 11, 2010||Jul 1, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods for monitoring renal neuromodulation|
|US8771252||May 20, 2005||Jul 8, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods and devices for renal nerve blocking|
|US8774913||Nov 14, 2006||Jul 8, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for intravasculary-induced neuromodulation|
|US8774922||May 21, 2013||Jul 8, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods|
|US8784463||Feb 12, 2013||Jul 22, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods for thermally-induced renal neuromodulation|
|US8805545||Apr 16, 2013||Aug 12, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for multi-vessel renal neuromodulation|
|US8818514||Jul 2, 2013||Aug 26, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Methods for intravascularly-induced neuromodulation|
|US8845629||Apr 5, 2010||Sep 30, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Ultrasound apparatuses for thermally-induced renal neuromodulation|
|US8852163||Jun 28, 2013||Oct 7, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods|
|US8880186||Apr 11, 2013||Nov 4, 2014||Medtronic Ardian Luxembourg S.A.R.L.||Renal neuromodulation for treatment of patients with chronic heart failure|
|US8934978||Apr 22, 2014||Jan 13, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for renal neuromodulation|
|US8948865||Nov 15, 2013||Feb 3, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods for treating heart arrhythmia|
|US8958871||Jan 14, 2011||Feb 17, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach|
|US8958883||Apr 19, 2006||Feb 17, 2015||Pierre-Yves Mueller||Electrical stimulation device and method for therapeutic treatment and pain management|
|US8983595||Nov 21, 2013||Mar 17, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Renal neuromodulation for treatment of patients with chronic heart failure|
|US8986294||Feb 4, 2010||Mar 24, 2015||Medtronic Ardian Luxembourg S.a.rl.||Apparatuses for thermally-induced renal neuromodulation|
|US9023037||Apr 23, 2013||May 5, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Balloon catheter apparatus for renal neuromodulation|
|US9072527||Jul 15, 2013||Jul 7, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Apparatuses and methods for renal neuromodulation|
|US9108040||Jun 26, 2014||Aug 18, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for multi-vessel renal neuromodulation|
|US9125661||Oct 17, 2013||Sep 8, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for renal neuromodulation|
|US9131978||Apr 23, 2014||Sep 15, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods for bilateral renal neuromodulation|
|US9138281||Sep 23, 2013||Sep 22, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets|
|US9186198||Sep 14, 2012||Nov 17, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Ultrasound apparatuses for thermally-induced renal neuromodulation and associated systems and methods|
|US9186213||May 15, 2014||Nov 17, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods for renal neuromodulation|
|US9192715||Mar 21, 2014||Nov 24, 2015||Medtronic Ardian Luxembourg S.A.R.L.||Methods for renal nerve blocking|
|US9265558||Apr 23, 2014||Feb 23, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for bilateral renal neuromodulation|
|US9289255||Mar 3, 2015||Mar 22, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for renal neuromodulation|
|US9308043||Nov 20, 2014||Apr 12, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for monopolar renal neuromodulation|
|US9308044||Nov 20, 2014||Apr 12, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for therapeutic renal neuromodulation|
|US9314630||Nov 20, 2014||Apr 19, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Renal neuromodulation for treatment of patients|
|US9320561||Nov 20, 2014||Apr 26, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for bilateral renal neuromodulation|
|US9326817||Dec 1, 2014||May 3, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for treating heart arrhythmia|
|US9327122||Feb 2, 2015||May 3, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for catheter-based renal neuromodulation|
|US9352151||Dec 30, 2013||May 31, 2016||Encore Medical Asset Corporation||Method and apparatus for applying neuromuscular electrical stimulation|
|US9364280||Dec 17, 2014||Jun 14, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach|
|US9402992||Jul 2, 2015||Aug 2, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for multi-vessel renal neuromodulation|
|US9439726||Mar 14, 2016||Sep 13, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for therapeutic renal neuromodulation|
|US9445867||Mar 21, 2016||Sep 20, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for renal neuromodulation via catheters having expandable treatment members|
|US9456869||Mar 14, 2016||Oct 4, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for bilateral renal neuromodulation|
|US9463066||Oct 8, 2015||Oct 11, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for renal neuromodulation|
|US9468497||Mar 14, 2016||Oct 18, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for monopolar renal neuromodulation|
|US9474563||Apr 16, 2014||Oct 25, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods for renal neuromodulation|
|US9486270||Aug 3, 2015||Nov 8, 2016||Medtronic Ardian Luxembourg S.A.R.L.||Methods and apparatus for bilateral renal neuromodulation|
|US20030074037 *||Oct 17, 2002||Apr 17, 2003||Rehabilicare, Inc.||Electrical nerve stimulation device|
|US20040015212 *||May 31, 2002||Jan 22, 2004||Empi, Corp.||Electrotherapy stimulation device having electrode peel off detection capabilities|
|US20040111130 *||Aug 6, 2003||Jun 10, 2004||Hrdlicka Gregory A.||Trial neuro stimulator with lead diagnostics|
|US20040176820 *||Dec 17, 2003||Sep 9, 2004||Paul Edward L.||Method and apparatus for performing microcurrent stimulation (MSC) therapy|
|US20050004628 *||Mar 15, 2002||Jan 6, 2005||Medtronic, Inc||Amplitude ramping of waveforms generated by an implantable medical device|
|US20050137649 *||Dec 15, 2003||Jun 23, 2005||Paul Edward L.Jr.||Method and apparatus for performing microcurrent stimulation (MSC) therapy|
|US20070216568 *||Nov 20, 2002||Sep 20, 2007||Martin Kunert||Fmcw Radar with Restricted Emission Time to Avoid Aliasing Effects|
|US20080114414 *||Jul 16, 2007||May 15, 2008||Moore Gary L||Electrical nerve stimulation device|
|US20120045026 *||Aug 20, 2010||Feb 23, 2012||Raytheon Company||Recovering distorted digital data|
|USRE40279||Jun 26, 1997||Apr 29, 2008||Sherwood Services Ag||Method and system for neural tissue modification|
|USRE41045||Jun 12, 2003||Dec 15, 2009||Covidien Ag||Method and apparatus for altering neural tissue function|
|U.S. Classification||607/63, 607/72|
|Jul 31, 2000||FPAY||Fee payment|
Year of fee payment: 8
|Apr 2, 2001||AS||Assignment|
Owner name: REHABILLICARE, INC. 1811 OLD HIGHWAY 8NEW BRIGHTON
Free format text: NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 3/18/98.;ASSIGNOR:STAODYN, INC. /AR;REEL/FRAME:011682/0185
Effective date: 20010329
|Sep 8, 2004||FPAY||Fee payment|
Year of fee payment: 12
|Sep 8, 2004||SULP||Surcharge for late payment|
Year of fee payment: 11
|Dec 13, 2007||AS||Assignment|
Owner name: CREDIT SUISSE, AS COLLATERAL AGENT, NEW YORK
Free format text: SECURITY AGREEMENT;ASSIGNOR:ENCORE MEDICAL ASSET CORPORATION;REEL/FRAME:020234/0433
Effective date: 20071120
|May 18, 2015||AS||Assignment|
Owner name: RIKCO INTERNATIONAL, LLC, WISCONSIN
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CREDIT SUISSE AG, AS COLLATERAL AGENT;REEL/FRAME:035706/0497
Effective date: 20150507
Owner name: ENCORE MEDICAL ASSET CORPORATION, CALIFORNIA
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CREDIT SUISSE AG, AS COLLATERAL AGENT;REEL/FRAME:035706/0497
Effective date: 20150507
Owner name: DJO, LLC, CALIFORNIA
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CREDIT SUISSE AG, AS COLLATERAL AGENT;REEL/FRAME:035706/0497
Effective date: 20150507